Related Experiment Video
Updated: Mar 2, 2026

Behavioral Approaches to Studying Innate Stress in Zebrafish
Published on: May 1, 2019
Effects of Buspirone on Agitation Associated With Dementia
Kenneth M Sakauye1, Cameron J Camp1, Patricia A Ford1
1Department of Geriatric Psychiatry, LSU Medical Center, New Orleans, Louisiana; Department of Woldenberg Center for Gerontological Studies, Touro Infirmary, New Orleans, Louisiana; Department of Psychology, University of New Orleans, Louisiana.
Abstract:
Ten patients with probable Alzheimer's disease participated in an open-label study of buspirone for agitation. The starting dose of 15 mg/day was increased by 5 mg every week until maximal improvement or 60 mg/day was reached. A significant decrease in agitation scores occurred at an average dose of 35 mg/day.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Anxiolytic Drugs: Benzodiazepines and Buspirone
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Alzheimer's Disease: Treatment
CNS Depressants: Barbiturates and Benzodiazepines
Antidepressant Drugs: MAOIs and Other Agents